Clinical translation of silica nanoparticles.

Nat Rev Mater

School of Pharmacy, The University of Queensland, Brisbane, Queensland Australia.

Published: October 2021

Silica nanoparticles have entered clinical trials for a variety of biomedical applications, including oral drug delivery, diagnostics, plasmonic resonance and photothermal ablation therapy. Preliminary results indicate the safety, efficacy and viability of silica nanoparticles under these clinical scenarios.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496429PMC
http://dx.doi.org/10.1038/s41578-021-00385-xDOI Listing

Publication Analysis

Top Keywords

silica nanoparticles
12
clinical translation
4
translation silica
4
nanoparticles silica
4
nanoparticles entered
4
entered clinical
4
clinical trials
4
trials variety
4
variety biomedical
4
biomedical applications
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!